Key facts
- BeSound’s last known valuation is $8.0M (Jul 2023).
- It has raised $9.2M; the latest was Seed Round ($6.8M) in Sep 2025.
- Notable investors include Mana Ventures, Lux Capital, Forum Ventures, Kindred Ventures, Arben Ventures — 15 tracked in total.
- Status: Privately Held (backing).
Leadership
- Bailey RengerChief Executive Officer & Founder
- John StancoChief Technology Officer & Founder
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for BeSound
- ·The full record, as it builds
Funding rounds
No funding rounds for BeSound are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BeSound
Developer of medical imaging devices designed to provide cancer diagnoses. The company specializes in providing an imaging technique that is accessible, high-resolution, and non-ionizing, enabling researchers to offer an accurate examination of cancer symptoms.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2023
- Employees
- 4
- Website
- besoundbreast.com/
- Ownership
- Privately Held (backing)
BeSound doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BeSound shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BeSound in its N-PORT filings yet. We sweep new filings monthly.